MedTrace Logo

Artificial Shrinkage for Human Blastocyst Prior Vitrification

NCT02976662 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-11-29

No results posted yet for this study

Summary

Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.

Conditions

  • Vitrification

Interventions

PROCEDURE

Artificial shrinkage

Artificially eliminated blastocoelic fluid before vitrification procedures.

Sponsors & Collaborators

  • Benha University

    collaborator OTHER

  • Dar AlMaraa Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02976662 on ClinicalTrials.gov